Metagenomi

About Metagenomi

Metagenomi Inc is a genomic medicines company specializing in the development of next-generation gene editing therapeutics. Leveraging metagenomics and artificial intelligence, Metagenomi discovers and engineers novel genome editing tools, including CRISPR-based systems, programmable nucleases, base editors, and integration systems such as prime editing and CRISPR-associated transposases. These technologies are used to create potentially curative therapies for a range of diseases, with a focus on precision, efficiency, and broad applicability. Metagenomi collaborates with partners to advance investigational medicines and gene-edited therapeutic products.